Note to users. If you're seeing this message, it means that your browser cannot find this page's style/presentation instructions -- or possibly that you are using a browser that does not support current Web standards. Find out more about why this message is appearing, and what you can do to make your experience of our site the best it can be.

Science 12 May 2000:
Vol. 288. no. 5468, pp. 954 - 955
DOI: 10.1126/science.288.5468.954
Prev | Table of Contents | Next

News Focus

BIOMEDICINE:
Gene Therapy's Web of Corporate Connections

Eliot Marshall

Researchers in gene therapy have become extremely sensitive about perceived conflicts between their financial and scientific portfolios, following the death last year of a volunteer in a clinical trial at the University of Pennsylvania's Institute for Human Gene Therapy (see main text). The trial used a technique for inserting genes into cells that was developed and patented by the institute's head, James Wilson. Wilson and Penn itself have a financial stake in a company Wilson founded to develop the technology.

Read the Full Text


THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES:
Antiviral Antibodies Target Adenovirus to Phagolysosomes and Amplify the Innate Immune Response.
A. K. Zaiss, A. Vilaysane, M. J. Cotter, S. A. Clark, H. C. Meijndert, P. Colarusso, R. M. Yates, V. Petrilli, J. Tschopp, and D. A. Muruve (2009)
J. Immunol. 182, 7058-7068
   Abstract »    Full Text »    PDF »
Activation of p38 and ERK Signaling during Adenovirus Vector Cell Entry Lead to Expression of the C-X-C Chemokine IP-10.
L. A. Tibbles, J. C. L. Spurrell, G. P. Bowen, Q. Liu, M. Lam, A. K. Zaiss, S. M. Robbins, M. D. Hollenberg, T. J. Wickham, and D. A. Muruve (2002)
J. Virol. 76, 1559-1568
   Abstract »    Full Text »    PDF »
Conflict-of-Interest Policies for Investigators in Clinical Trials.
B. Lo, L. E. Wolf, and A. Berkeley (2000)
N. Engl. J. Med. 343, 1616-1620
   Abstract »    Full Text »    PDF »


To Advertise     Find Products

Science. ISSN 0036-8075 (print), 1095-9203 (online)